Saule Iskakova
Research Subjects
Saule Iskakova has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Agnieszka Stelmaszyk
Department of Pharmacology, Poznan University of Medical Sciences, Poznan, Poland
1 shared publication - Anna Maliszewska-Dworacka1 shared publication
- Anna Wesołowska
Department of Pharmacology, Poznan University of Medical Sciences, Rokietnicka Street 3, 60-806 Poznan, Poland
1 shared publication - Bartosz Adam Frycz
Department of Biochemistry and Molecular Biology, Poznan University of Medical Sciences, Święcickiego 6, 60-781 Poznań, Poland
1 shared publication - Marcin Ożarowski
Department of Biotechnology, Institute of Natural Fibres and Medicinal Plants - National Research Institute, Poznań, Poland
1 shared publication - Marzena Dworacka
Department of Pharmacology, Poznan University of Medical Sciences, Poznan, Poland
1 shared publication
Latest Publications
- Open Access
- 29 December 2025
- Published by Poznan University of Medical Sciences in Journal of Medical Science
- Vol. 94 (4)
Passiflora incarnata extract-induced VEGF and TGF-β1 mRNA expression in the cardiovascular system using the rat model of type 2 diabetes
Aim. To investigate the possible effects of Passiflora extract on VEGF and TGF-β1 mRNA expression – growth factors closely related to the development of diabetes in the cardiovascular system. Material and methods. The animal model of type 2 diabetes, rich-fat/STZ Wistar rats, was used. Animals were randomised into four groups: Passiflora-treated type 2 diabetes mellitus model group; metformin-treated type 2 diabetes mellitus model group; placebo-treated type 2 diabetes mellitus model group; and placebo-treated non-diabetic control group. Passiflora incarnata leaf extract was administered orally once daily for eight consecutive weeks. mRNA VEGF, VEGF-R1, VEGF-R2 and TGF-β1 expression were measured in the myocardium and the aorta. Results. Passiflora incarnata extract increases VEGF and VEGFR2 mRNA expression in the myocardium of rats with type 2 diabetes and decreases expression in the aortal wall. The expression of TGF-β1 mRNA in both the myocardium and the aorta is reduced in Passiflora incarnata-treated rats with diabetes. Most observed effects are independent of the animals' current metabolic status. Conclusions. The current data provide novel findings on the beneficial effects of Passiflora extract on the myocardium in the context of type 2 diabetes, potentially through mechanisms involving VEGF and TGF-β1. However, the significance of the impact of Passiflora extract on the aorta wall via VEGF and TGF-β1 is uncertain.
- 29 December 2025
- Published by Poznan University of Medical Sciences in Journal of Medical Science
- Vol. 94 (4)
Open AccessPassiflora incarnata extract-induced VEGF and TGF-β1 mRNA expression in the cardiovascular system using the rat model of type 2 diabetes
Aim. To investigate the possible effects of Passiflora extract on VEGF and TGF-β1 mRNA expression – growth factors closely related to the development of diabetes in the cardiovascular system. Material and methods. The animal model of type 2 diabetes, rich-fat/STZ Wistar rats, was used. Animals were randomised into four groups: Passiflora-treated type 2 diabetes mellitus model group; metformin-treated type 2 diabetes mellitus model group; placebo-treated type 2 diabetes mellitus model group; and placebo-treated non-diabetic control group. Passiflora incarnata leaf extract was administered orally once daily for eight consecutive weeks. mRNA VEGF, VEGF-R1, VEGF-R2 and TGF-β1 expression were measured in the myocardium and the aorta. Results. Passiflora incarnata extract increases VEGF and VEGFR2 mRNA expression in the myocardium of rats with type 2 diabetes and decreases expression in the aortal wall. The expression of TGF-β1 mRNA in both the myocardium and the aorta is reduced in Passiflora incarnata-treated rats with diabetes. Most observed effects are independent of the animals' current metabolic status. Conclusions. The current data provide novel findings on the beneficial effects of Passiflora extract on the myocardium in the context of type 2 diabetes, potentially through mechanisms involving VEGF and TGF-β1. However, the significance of the impact of Passiflora extract on the aorta wall via VEGF and TGF-β1 is uncertain.